Ureteroscopy-assisted retrograde nephrostomy (UARN) without ureteral access sheath (UAS).

We previously described ureteroscopy assisted retrograde nephrostomy (UARN). In UARN, it is possible to continuously visualize the dilation of the ure...
716KB Sizes 2 Downloads 27 Views

Recommend Documents

Rigid Ureteroscope Aided Insertion of Ureteral Access Sheath in Retrograde Intrarenal Surgery.
To compare the outcomes of the ureteral access sheath (UAS) placement techniques in patients undergoing retrograde intrarenal surgery.

Benefits and risks of ureteral access sheaths for retrograde renal access.
Ureteral access sheath (UAS) became increasingly popular worldwide. However, the safety of its routine use remains controversial. The aim of the current revision is to provide a systematic review on the benefits and disadvantages of the UAS.

Predicting an effective ureteral access sheath insertion: a bicenter prospective study.
The use of a ureteral access sheath (UAS) may provide significant advantages, particularly, in the treatment of a large renal stone burden. However, in some patients, the passage of a UAS up the ureter is impossible. We prospectively evaluated the ab

Ureteroscopy assisted retrograde nephrostomy for complete staghorn renal calculi.
Complete staghorn calculi are typically managed with percutaneous nephrolithotomy (PCNL). However, dilating nephrostomy and inserting a nephro access sheath can be difficult to perform without hydronephrosis. We reported the procedure of ureteroscopy

Comparison between Double J (DJ) Ureteral Stenting and Percutaneous Nephrostomy (PCN) in Obstructive Uropathy.
To compare the complications rate of percutaneous nephrostomy and double J ureteral stenting in the management of obstructive uropathy.

Predicting the failure of retrograde ureteral stent insertion for managing malignant ureteral obstruction in outpatients.
Malignant ureteral obstruction (MUO) is an unpropitious sign that is commonly observed in patients with advanced incurable cancer. The present study aimed to evaluate predictive factors for the failure of retrograde ureteral stent insertion in the ma